Record NNP B-NP O
date NN I-NP O
: : O O
2091-06-12 CD O B-DATE
Narrative JJ B-NP O
History NN I-NP O
79 CD B-NP B-AGE
yo NNP I-NP O
woman NN I-NP O
who WP B-NP O
presents VBZ B-VP O
for IN B-PP O
f/u NN B-NP O
of IN B-LST O
: : O O
1 LS O O
. . B-NP O
Urinary NNP I-NP O
incontinence NN I-NP O
: : O O
She PRP B-NP O
is VBZ B-VP O
s/p JJ B-NP O
vaginal JJ I-NP O
sling NN I-NP O
procedure NN I-NP O
by IN B-PP O
Dr. NNP B-NP O
Xuereb NNP I-NP B-DOCTOR
in IN B-PP O
April NNP B-NP B-DATE
. . O O
She PRP B-NP O
states VBZ B-VP O
that IN B-SBAR O
she PRP B-NP O
did VBD B-VP O
well RB B-ADJP O
for IN B-PP O
about IN B-NP O
2 CD I-NP O
weeks NNS I-NP O
, , O O
but CC O O
then RB B-ADVP O
the DT B-NP O
incontinence NN I-NP O
became VBD B-VP O
worse JJR B-ADJP O
than IN B-PP O
before IN B-NP O
. . O O
According VBG B-VP O
to TO B-PP O
her PRP$ B-NP O
son NN I-NP O
, , O O
she PRP B-NP O
saw VBD B-VP O
Dr. NNP B-NP O
Xuereb NNP I-NP B-DOCTOR
10 CD I-NP O
days NNS I-NP O
ago IN B-PP O
who WP B-NP O
thought VBD B-VP O
the DT B-NP O
procedure NN I-NP O
was VBD B-VP O
a DT B-NP O
success NN I-NP O
but CC O O
that IN B-SBAR O
the DT B-NP O
pt NN I-NP O
had VBD B-VP O
a DT B-NP O
UTI. NNP I-NP O
She PRP B-NP O
started VBD B-VP O
her PRP B-NP O
on IN B-PP O
a DT B-NP O
month-long JJ I-NP O
course NN I-NP O
of IN B-PP O
nitrofurantoin NN B-NP O
. . O O
2. DT B-NP O
PAF NNP I-NP O
: : O O
The DT B-NP O
pt NN I-NP O
has VBZ B-VP O
not RB I-VP O
noted VBN I-VP O
any DT B-NP O
cardiac NN I-NP O
symptoms NNS I-NP O
. . O O
3. DT B-NP O
PMR NNP I-NP O
: : O O
Her PRP$ B-NP O
shoulder NN I-NP O
pain NN I-NP O
and CC O O
weakness NN B-NP O
has VBZ B-VP O
disappeared VBN I-VP O
since IN B-PP O
starting VBG B-VP O
the DT B-NP O
Prednisone NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
noted VBN I-VP O
some DT B-NP O
facial JJ I-NP O
puffiness NN I-NP O
since IN B-PP O
the DT B-NP O
medication NN I-NP O
was VBD B-VP O
begun VBN I-VP O
. . O O
She PRP B-NP O
is VBZ B-VP O
being VBG I-VP O
followed VBN I-VP O
in IN B-PP O
Rheum NNP B-NP O
by IN B-PP O
Dr. NNP B-NP O
Lisa NNP I-NP B-DOCTOR
Inge NNP I-NP I-DOCTOR
. . O O
4 CD B-LST O
. . O O
Mental NNP B-NP O
status NN I-NP O
: : O O
She PRP B-NP O
underwent JJ B-NP O
neuropsychiatric JJ I-NP O
testing NN I-NP O
at IN B-PP O
BMA NNP B-NP B-HOSPITAL
3 CD I-NP O
days NNS I-NP O
ago RB B-ADVP O
and CC O O
the DT B-NP O
results NNS I-NP O
have VBP B-VP O
been VBN I-VP O
faxed VBN I-VP O
to TO B-PP O
BH NNP B-NP B-HOSPITAL
. . O O
5 CD B-NP O
. . O O
Social NNP B-NP O
: : O O
She PRP B-NP O
is VBZ B-VP O
currently RB I-VP O
living VBG I-VP O
in IN B-PP O
Forest NNP B-NP B-HOSPITAL
Hills NNPS I-NP I-HOSPITAL
, , O O
an DT B-NP O
assisted VBN I-NP O
living NN I-NP O
facility NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
her PRP$ B-NP O
own JJ I-NP O
bedroom NN I-NP O
and CC O O
sitting VBG B-VP O
room NN B-NP O
and CC O O
can MD B-VP O
shut VB I-VP O
her PRP$ B-NP O
door NN I-NP O
for IN B-PP O
privacy NN B-NP O
. . O O
All DT B-NP O
meals NNS I-NP O
are VBP B-VP O
provided VBN I-VP O
for IN B-PP O
her PRP B-NP O
. . O O
She PRP B-NP O
enjoys VBZ B-VP O
the DT B-NP O
room NN I-NP O
but CC B-PP O
at IN B-PP O
times NNS B-NP O
feels VBZ B-VP O
" `` O O
confined VBN B-VP O
. . O O
" '' O O
She PRP B-NP O
had VBD B-VP O
befriended VBN I-VP O
a DT B-NP O
90 CD I-NP B-AGE
yo NNP I-NP O
male JJ I-NP O
patient NN I-NP O
, , O O
but CC O O
recently RB B-VP O
had VBD I-VP O
a DT B-NP O
bad JJ I-NP O
experience NN I-NP O
when WRB B-ADVP O
he PRP B-NP O
made VBD B-VP O
sexual JJ B-NP O
advances NNS I-NP O
toward IN B-PP O
her PRP B-NP O
. . O O
She PRP B-NP O
states VBZ B-VP O
that IN B-SBAR O
she PRP B-NP O
would MD B-VP O
like VB I-VP O
to TO I-VP O
move VB I-VP O
back RB B-ADVP O
into IN B-PP O
her PRP$ B-NP O
apartment NN I-NP O
in IN B-PP O
Stow NNP B-NP B-CITY
. . O O
Problems NNS B-NP O
Urinary JJ B-NP O
incontinence NN I-NP O
s/p RB B-NP O
sling JJ I-NP O
procedure NN I-NP O
in IN B-PP O
4/91 CD B-NP B-DATE
; : O O
s/p NN B-NP O
3 CD I-NP O
prior JJ I-NP O
bladder NN I-NP O
suspension NN I-NP O
surgeries NNS I-NP O
Hypertension NN B-NP O
Depression NN B-NP O
Elevated VBN B-NP O
cholesterol NN I-NP O
Diarrhea NN B-NP O
Polymyalgia NNP B-NP O
rheumatica NNP I-NP O
diagnosed VBD B-VP O
in IN B-PP O
1/91 CD B-NP B-DATE
S/P JJ B-NP O
rectocele NN I-NP O
repair NN I-NP O
Paroxysmal JJ B-NP O
atrial NN I-NP O
fibrillation NN I-NP O
controlled VBN B-VP O
with IN B-PP O
medication NN B-NP O
Peripheral JJ B-NP O
neuropathy NN I-NP O
unclear JJ B-NP O
etiology NN I-NP O
Hyperlipidemia NNP B-NP O
H/O NNP B-NP O
Alcohol NNP I-NP O
abuse NN I-NP O
S/P NNP B-NP O
urosepsis NN I-NP O
admission NN I-NP O
in IN B-PP O
9/90 CD B-NP B-DATE
chronic NN B-NP O
diarrhea NN I-NP O
colonoscopy NN I-NP O
attempted VBN B-VP O
in IN B-PP O
9/90 CD B-NP B-DATE
but CC O O
pt VBD B-VP O
not RB O O
able JJ B-ADJP O
to TO B-VP O
tolerate VB I-VP O
procedure NN B-NP O
Dementia NNP B-NP O
Mild-moderate NNP I-NP O
; : O O
neuropsychiatric JJ B-NP O
test NN I-NP O
done VBN B-VP O
in IN B-PP O
5/91 CD B-NP B-DATE
Medications NNS B-NP O
FOLIC NN B-NP O
ACID NNP I-NP O
1MG VBD B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
ECOTRIN NNP B-NP O
( -LRB- I-NP O
ASPIRIN NNP I-NP O
ENTERIC NNP I-NP O
COATED NNP I-NP O
) -RRB- I-NP O
325MG JJ I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
REMERON NN B-NP O
( -LRB- I-NP O
MIRTAZAPINE NNP I-NP O
) -RRB- I-NP O
15MG . B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QHS . O O
METOPROLOL NNP B-NP O
TARTRATE NNP I-NP O
50MG VBD B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
TID NN I-NP O
SOTALOL NNP B-NP O
80MG VBD B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
BID . O O
THIAMINE NNP B-NP O
HCL NNP I-NP O
100MG VBD B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
PREDNISONE JJ B-NP O
12.5MG CD I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QAM NN I-NP O
VIOXX NNP B-NP O
( -LRB- I-NP O
ROFECOXIB NN I-NP O
) -RRB- I-NP O
12.5MG CD I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NNP I-NP O
QD NNP I-NP O
PRN NNP I-NP O
. . O O
DIGOXIN NNP B-NP O
0.125MG NNP I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
FERROUS NNP B-NP O
SULFATE NNP I-NP O
325MG NNP I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
MVI NNS B-NP O
( -LRB- B-VP O
MULTIVITAMINS NNS B-NP O
) -RRB- I-NP O
1 CD I-NP O
CAPSULE NNP I-NP O
PO NNP I-NP O
QD . O O
CALCIUM NNP B-NP O
CARBONATE NNP I-NP O
VIT NNP I-NP O
D(1TABLET=250MG NNP I-NP O
E... NNP I-NP O
500 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
TID NNP I-NP O
FOSAMAX NN B-NP O
( -LRB- I-NP O
ALENDRONATE NNP I-NP O
) -RRB- I-NP O
70MG NNP I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QWEEK NN I-NP O
NITROFURANTOIN NNP B-NP O
100MG VBD B-VP O
1 CD B-NP O
Capsule( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Allergies . O O
NKDA NNP B-NP O
Review NNP B-NP O
of IN I-NP O
Systems NNPS O O
No DT B-NP O
change NN I-NP O
in IN B-PP O
appetite NN B-NP O
. . O O
No DT B-NP O
F/C NNP I-NP O
, , O O
cough NN B-NP O
, , O O
SOB NNP B-NP O
, , O O
CP CD B-NP O
, , O O
abd NN B-NP O
pain NN I-NP O
, , O O
diarrhea NN B-NP O
, , O O
constipation NN B-NP O
, , O O
dysuria NN B-NP O
, , O O
or CC O O
joint JJ B-NP O
pains NNS I-NP O
. . O O
Physical NNP B-NP O
Exam NNP I-NP O
BP NNP B-NP O
: : O O
140/8 CD B-NP O
0 CD I-NP O
Weight NNP I-NP O
: : O O
133 CD B-NP O
lbs NNS I-NP O
(up IN B-PP O
15 CD B-NP O
lbs NNS I-NP O
since IN B-PP O
12/90 CD B-NP B-DATE
) -RRB- O O
General NNP B-NP O
Appearance NNP I-NP O
Appears NNP B-NP O
healthy JJ I-NP O
; : O O
facial JJ B-NP O
swelling VBG I-NP O
. . O O
Cor/Cardiac NNP B-NP O
RRR NN B-NP O
; : O O
S1S2 NNP B-NP O
with IN B-PP O
II/V NNP B-NP O
I PRP B-NP O
SEM VBP B-VP O
at IN B-PP O
LLSB NNP B-NP O
; : O O
no DT B-NP O
rubs NNS I-NP O
or CC I-NP O
gallops NNS I-NP O
. . O O
Laboratory NNP B-NP O
Data NNPS I-NP O
Neuropsychiatric JJ B-NP O
testing NN I-NP O
( -LRB- B-NP O
summary NN I-NP O
of IN B-PP O
results NNS B-NP O
) -RRB- I-NP O
: : O O
Dementia NN B-NP O
of IN B-PP O
mild JJ B-NP O
to TO B-PP O
moderate JJ B-NP O
severity NN I-NP O
; : O O
pattern NN B-NP O
of IN B-PP O
deficits NNS B-NP O
is VBZ B-VP O
consistent JJ B-ADJP O
with IN B-PP O
primary JJ B-NP O
neurodegenerative JJ I-NP O
process NN I-NP O
( -LRB- B-NP O
i FW B-VP O
.e FW B-NP O
. . O O
, , O O
Alzheimer NNP B-NP O
's POS B-NP O
) -RRB- I-NP O
; : O O
will MD B-VP O
impact VB I-VP O
her PRP$ B-NP O
ability NN I-NP O
to TO B-VP O
function VB I-VP O
independently RB B-ADVP O
. . O O
Assessment NNP B-NP O
and CC I-NP O
Plan NNP I-NP O
1 LS O O
. . B-NP O
Incontinence NNP I-NP O
: : O O
F/u NNP B-NP O
with IN B-PP O
Dr. NNP B-NP O
Xuereb NNP I-NP B-DOCTOR
after IN B-PP O
completing VBG B-VP O
course NN B-NP O
of IN B-PP O
nitrofurantoin NN B-NP O
. . O O
2. DT B-NP O
Cardiac NNP I-NP O
: : O O
Stable JJ B-NP O
on IN B-PP O
metoprolol NN B-NP O
, , O O
sotalol NN B-NP O
, , O O
and CC O O
digoxin NN B-NP O
. . O O
3. DT B-NP O
PMR NNP I-NP O
: : O O
Continue NNP B-NP O
low-dose NN I-NP O
prednisone NN I-NP O
. . O O
Discussed VBN B-VP O
facial JJ B-NP O
bloating NN I-NP O
as IN B-PP O
side NN B-NP O
effect NN I-NP O
. . O O
Plan NNP O O
according VBG B-PP O
to TO B-PP O
Dr. NNP B-NP O
Inge NNP I-NP B-DOCTOR
is VBZ B-VP O
to TO I-VP O
taper VB I-VP O
prednisone NN B-NP O
slowly RB B-ADVP O
over IN B-PP O
a DT B-NP O
year NN I-NP O
. . O O
Will MD B-VP O
check VB I-VP O
ESR NNP B-NP O
today NN B-NP O
. . O O
4 LS O O
. . B-NP O
Depression NNP I-NP O
: : O O
Much JJ B-NP O
better JJR I-NP O
. . O O
No DT B-NP O
physical JJ I-NP O
signs/sx NN I-NP O
of IN B-PP O
depression NN B-NP O
right RB B-ADVP O
now RB I-ADVP O
. . O O
Continue JJ B-NP O
Remeron NNP I-NP O
. . O O
5 CD B-NP O
. . O O
Dementia NNP B-NP O
: : O O
It PRP B-NP O
was VBD B-VP O
suggested VBN I-VP O
in IN B-PP O
the DT B-NP O
neuropsych JJ I-NP O
evaluation NN I-NP O
that IN B-PP O
a DT B-NP O
cognitive JJ I-NP O
enhancing NN I-NP O
medication NN I-NP O
may MD B-VP O
benefit VB I-VP O
the DT B-NP O
pt NN I-NP O
. . O O
Will MD B-VP O
discuss VB I-VP O
starting VBG I-VP O
Aricept FW B-NP O
with IN B-PP O
pt NN B-NP O
's POS B-NP O
cardiologist NN I-NP O
, , O O
Dr. NNP B-NP O
Jankowski NNP I-NP B-DOCTOR
, , O O
to TO B-VP O
make VB I-VP O
sure JJ B-ADJP O
it PRP B-NP O
will MD B-VP O
not RB I-VP O
impact VB I-VP O
her PRP$ B-NP O
Afib NNP I-NP O
. . O O
6 CD B-NP O
. . O O
Hyperlipidemia NNP B-NP O
: : O O
Lipitor NNP B-NP O
was VBD B-VP O
d/c JJ B-NP O
'd NNP I-NP O
at IN B-PP O
some DT B-NP O
point NN I-NP O
over IN B-PP O
past JJ B-NP O
year NN I-NP O
. . O O
Will MD B-VP O
check VB I-VP O
chol/HDL NN B-NP O
today NN I-NP O
since IN B-SBAR O
she PRP B-NP O
is VBZ B-VP O
not RB I-VP O
fasting VBG I-VP O
. . O O
7. DT B-NP O
Social NNP I-NP O
: : O O
Discussed VBN B-NP O
results NNS I-NP O
of IN B-PP O
neuropsych JJ B-NP O
evaluation NN I-NP O
with IN B-PP O
patient NN B-NP O
. . O O
Discussed VBN B-NP O
issues NNS I-NP O
of IN B-PP O
living VBG B-VP O
alone RB B-ADVP O
and CC O O
how WRB B-ADVP O
she PRP B-NP O
would MD B-VP O
need VB I-VP O
24 CD B-NP O
hour NN I-NP O
supervision NN I-NP O
. . O O
Pt NNP O O
not RB O O
sure JJ B-ADJP O
if IN B-SBAR O
this DT B-NP O
situation NN I-NP O
would MD B-VP O
be VB I-VP O
better JJR B-ADJP O
than IN B-PP O
assisted VBN B-NP O
living NN I-NP O
. . B-VP O
Discussed VBN I-VP O
these DT B-NP O
issues NNS I-NP O
with IN B-PP O
pt NN B-NP O
's POS B-NP O
son NN I-NP O
, , O O
Villatoro NNP B-NP B-PATIENT
, , O O
over IN B-PP O
the DT B-NP O
phone NN I-NP O
after IN B-PP O
the DT B-NP O
visit NN I-NP O
. . O O
Will MD O O
fax NN B-VP O
him PRP B-NP O
paperwork NN B-VP O
for IN B-PP O
health NN B-NP O
care NN I-NP O
proxy NN I-NP O
. . O O
